TAOX
TAO Synergies Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.57
+12.01%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 96.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.98x
- Price / sales
- 44.27x
- Price / cash flow
- -5.51x
Enterprise value
- Enterprise value
- $19.6M
- EV / sales
- 25.33x
- EV / EBITDA
- -2.33x
- EV / EBIT
- -2.33x
- Market cap
- $34.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026